Table 2.
Category | Cases | Drug resistant† | MDR‡ | |||
---|---|---|---|---|---|---|
HR | HRE | HRS | HRSE | |||
n(%) | n(%) | n(%) | n(%) | n(%) | ||
Total | 1824 | 37(2.03) | 26(1.43) | 94(5.15) | 146(8.00) | 303(16.61) |
New cases | 1180 | 9(0.76) | 5(0.42) | 33(2.80) | 43(3.64) | 90(7.63) |
Previously treated cases | 644 | 28(4.35) | 21(3.26) | 61(9.47) | 103(15.99) | 213(33.07) |
χ2 | 26.95 | 23.87 | 37.98 | 86.29 | 194.76 | |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
†: HR: isoniazid+rifampicin; HRE: isoniazid+rifampicin+ethambutol;
HRS: isoniazid+rifampicin+streptomycin;
HRSE: isoniazid+rifampicin+streptomycin+ethambutol
‡: MDR, resistant to at least isoniazid and rifampicin